69 results
Page 3 of 4
20-F
EX-12.1
69qc 47nf9m9
18 Mar 21
Annual report (foreign)
9:03am
20-F
EX-12.2
5xsdu4x6 e1yw
18 Mar 21
Annual report (foreign)
9:03am
20-F
wjfkz7qltroweuvcuo1g
18 Mar 21
Annual report (foreign)
9:03am
6-K
EX-10.3
43rbklkg3cc
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
EX-10.1
zscirrl 0jrxc
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
EX-10.2
lqa3n7r8i5zdt3yerezp
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
EX-99.1
vh8wwgz
19 Jan 21
Extraordinary General Meeting of Shareholders
4:35pm
6-K
EX-99.1
j8j89pvv yo7r4nx1
6 Jan 21
PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations
9:00am
6-K
EX-99.1
j1zof zhchdj5q
5 Jan 21
Investor Presentation January 2021
4:15pm
424B3
bqd72eyixk0b
25 Nov 20
Prospectus supplement
11:12am
6-K
EX-99.1
gab8 cf9gvy0unq
25 Nov 20
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
10:08am
424B4
ip7nv84kqc4rphsx3d
2 Sep 20
Prospectus supplement with pricing info
4:09pm
F-1/A
EX-3.2
x2gxmsxyamh5s9fqu7op
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
3rs9jhcvatiisg
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
EX-10.6
cywnrbwsvb9nskdar9t
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
4a7 dqe3t
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
EX-10.5
zfzt 6c7444
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
EX-1.1
4rdqi
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
0co ipx94
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
uuxhbj
5 Aug 20
Registration statement (foreign) (amended)
1:26pm